OneShot Renal Denervation Registry
Phase 2
Terminated
- Conditions
- Sleep ApneaHeart FailureDiabetes MellitusHypertension
- Interventions
- Device: OneShot Ablation System
- Registration Number
- NCT01844037
- Lead Sponsor
- Medtronic Endovascular
- Brief Summary
This is a multi-center, prospective registry designed to monitor the outcomes of renal denervation with the OneShot Device in a real-world patient population.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 51
Inclusion Criteria
- Patient is an acceptable candidate for renal denervation based upon the Instructions for Use.
- Patient is ≥ 18 years old.
- Patient provided written informed consent.
Exclusion Criteria
- Patients who are pregnant, nursing, or planning to become pregnant.
- Patients who have only one functioning kidney.
- Allergy to contrast or known hypersensitivity to device materials
- Patients with renal arteries < 4 mm in diameter.
- Patients whose life expectancy is less than the planned period of study involvement.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Renal denervation OneShot Ablation System Patients will be treated with the OneShot ablation system
- Primary Outcome Measures
Name Time Method Change in office systolic blood pressure (SBP) from baseline to 6 months 6 months
- Secondary Outcome Measures
Name Time Method Acute procedural safety, defined as freedom from renal artery dissection or perforation requiring intervention. One Week Change in office diastolic blood pressure (DBP) 6 and 12 months post procedure Change in office SBP 6 and 12 months post procedure
Trial Locations
- Locations (1)
Hospital San Raffaele
🇮🇹Milano, Italy